help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on July 11, 2002
Molecular Endocrinology, doi:10.1210/me.2002-0083
Molecular Endocrinology Vol. 0, No. 2002 200200831-
doi:10.1210/me.2002-0083
Copyright © 2002 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
16/10/2371    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishihara, H.
Right arrow Articles by Kobayashi, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ishihara, H.
Right arrow Articles by Kobayashi, M.

Submitted on February 25, 2002
Accepted on June 11, 2002

Membrane Localization of SHIP2 via Shc Association is Required for the Negative Regulation of Insulin Signaling in Rat1 Fibroblasts Overexpressing Insulin Receptors

Hajime Ishihara1, Toshiyasu Sasaoka1*, Manabu Ishiki1, Tsutomu Wada1, Hiroyuki Hori1, Syota Kagawa1, and Masashi Kobayashi1

1 From the First Department of Internal Medicine and the Department of Clinical Pharmacology, Toyama Medical & Pharmaceutical University, Toyama 930-0194, and the Sainou Hospital, Toyama 930-0887, Japan

* To whom correspondence should be addressed. E-mail: tsasaoka-tym{at}umin.ac.jp.

Lipid phosphatase SHIP2 has been shown to be a physiologically critical negative regulator of insulin signaling. We investigated the molecular mechanism by which SHIP2 negatively regulates insulin-induced phosphorylation of Akt, a key downstream molecule of PI3-kinase important for the biological action of insulin. Overexpression of wild-type SHIP2 (WT-SHIP2) inhibited insulin-induced phosphorylation of Akt at both Thr308 and Ser473 in Rat1 fibroblasts expressing insulin receptors. The degree of inhibition was less in the cells expressing either a mutant SHIP2 with R47Q change (R/Q-SHIP2) in the SH2 domain, or a mutant SHIP2 with Y987F change (Y/F-SHIP2) in the C-terminal tyrosine phosphorylation site. However, on addition of a myristoylation signal, WT-SHIP2, R/Q-SHIP2, and Y/F-SHIP2 all efficiently inhibited insulin-induced Akt phosphorylation at both residues, whereas a 5'-phosphatase defective mutant SHIP2 ({Delta}IP-SHIP2) with the myristoylation signal did not. Interestingly, the degree of inhibition of Akt phosphorylation by R/Q-SHIP2 and Y/F-SHIP2 is well correlated with the extent of their association with Shc. In addition, overexpression of WT-Shc increased the insulin-induced association of SHIP2 with Shc, whereas a decrease in the amount of Shc on expression of antisense Shc mRNA (AS-Shc) led to a reduction in the SHIP2|b7Shc association. Furthermore, the inhibitory effect on insulin-induced Akt phosphorylation by WT-SHIP2 was decreased in AS-Shc cells. These results indicate that the membrane localization of SHIP2 with its 5'-phosphatase activity is required for negative regulation of insulin-induced Akt phosphorylation and that the localization is regulated, at least in part, by the association of SHIP2 with Shc in Rat1 fibroblasts.


Key words: Insulin • SHIP2 • Lipid phosphatase • Akt • Shc




This article has been cited by other articles:


Home page
J. Immunol.Home page
W.-H. Leung and S. Bolland
The Inositol 5'-Phosphatase SHIP-2 Negatively Regulates IgE-Induced Mast Cell Degranulation and Cytokine Production
J. Immunol., July 1, 2007; 179(1): 95 - 102.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Ananthanarayanan, Q. Ni, and J. Zhang
Signal propagation from membrane messengers to nuclear effectors revealed by reporters of phosphoinositide dynamics and Akt activity
PNAS, October 18, 2005; 102(42): 15081 - 15086.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Kagawa, T. Sasaoka, S. Yaguchi, H. Ishihara, H. Tsuneki, S. Murakami, K. Fukui, T. Wada, S. Kobayashi, I. Kimura, et al.
Impact of Src Homology 2-Containing Inositol 5'-Phosphatase 2 Gene Polymorphisms Detected in a Japanese Population on Insulin Signaling
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2911 - 2919.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Murakami, T. Sasaoka, T. Wada, K. Fukui, K. Nagira, H. Ishihara, I. Usui, and M. Kobayashi
Impact of Src Homology 2-Containing Inositol 5'-Phosphatase 2 on the Regulation of Insulin Signaling Leading to Protein Synthesis in 3T3-L1 Adipocytes Cultured with Excess Amino Acids
Endocrinology, July 1, 2004; 145(7): 3215 - 3223.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Sasaoka, T. Wada, K. Fukui, S. Murakami, H. Ishihara, R. Suzuki, K. Tobe, T. Kadowaki, and M. Kobayashi
SH2-containing Inositol Phosphatase 2 Predominantly Regulates Akt2, and Not Akt1, Phosphorylation at the Plasma Membrane in Response to Insulin in 3T3-L1 Adipocytes
J. Biol. Chem., April 9, 2004; 279(15): 14835 - 14843.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society